[company_age]7.0[/company_age][employees]1-10 employees[/employees][funding]seed[/funding][description]Avisi Technologies is a medical technology company dedicated to developing innovative solutions for glaucoma, the leading cause of irreversible blindness globally. Established in 2017, the company operates from its headquarters in Redwood City, California, and enjoys the support of venture investors, prestigious universities, and industry groups. Avisi's flagship product, VisiPlate, is an investigational nanotechnology-enabled aqueous shunt designed to offer a safe and effective treatment for glaucoma. The company's team comprises experts in materials science engineering, ophthalmology, and business, united by a shared vision of creating accessible, cutting-edge healthcare solutions for all.[/description][ps]VisiPlate, an investigational nanotechnology-enabled aqueous shunt for glaucoma treatment.[/ps]